15.01.2013 Views

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

History <strong>of</strong> the <strong>Mitochondrial</strong> <strong>Free</strong> <strong>Radical</strong> <strong>The</strong>ory <strong>of</strong> <strong>Aging</strong>, 1954-1995<br />

concentrations <strong>of</strong> mutations. He therefore concluded that, most probably, point mutations<br />

never accumulate at all, and the contrary findings that had been published by other labs<br />

were artifacts <strong>of</strong> their experimental techniques. <strong>The</strong> other possibility, <strong>of</strong> course, was that<br />

there was something unusual about the particular region <strong>of</strong> the mtDNA that Schon had<br />

assayed (within the gene for ATPase subunit 6); but nothing <strong>of</strong> that kind was apparent, so<br />

this formal possibility was not—at that time—considered.<br />

6.6.5. Inherited mtDNA-Linked Diseases; <strong>The</strong> Threshold Effect<br />

Just as it is difficult to extrapolate confidently from observations in rapidly dividing<br />

cells in vitro to the situation in non-dividing cells in vivo, so there are pitfalls in extrapolating<br />

from the phenotypes caused by genetic abnormalities to those that exist in normal aging. It<br />

is very tempting—and by no means always fruitless—to do this when the macroscopic<br />

phenotype <strong>of</strong> the disorder resembles accelerated aging, such as in Werner’s syndrome. It is<br />

equally tempting when the similarity is at a microscopic scale, and, indeed, several disorders<br />

exist in which mutant mtDNA appears to accumulate in a way similar to that in normal<br />

aging, but faster, <strong>of</strong>ten leading to early mortality. <strong>The</strong> similarities are great: the same tissues<br />

(non-dividing ones, particularly those with high energy demand) are most affected, and the<br />

levels <strong>of</strong> activity <strong>of</strong> mt-coded enzymes (such as cytochrome c oxidase) exhibit the same<br />

mosaic, “all-or-none” distribution with some cells (or fiber segments) having no activity<br />

while the rest have normal activity 79<br />

<strong>The</strong> differences are also rather striking, however, and immediately give reason for<br />

caution. One great potential value <strong>of</strong> these diseases for the study <strong>of</strong> mtDNA dysfunction is<br />

that they are caused by the presence <strong>of</strong> the same mutation in every affected cell, so that the<br />

total level <strong>of</strong> mutant mtDNA in a tissue sample can be assessed quite accurately, in contrast<br />

to the situation in normal aging discussed in the previous section. But when this is done,<br />

patients are <strong>of</strong>ten found to have very large amounts <strong>of</strong> mutant mtDNA—sometimes over<br />

50% by the time their symptoms have become severe. 80,81 <strong>The</strong> shortcomings <strong>of</strong> quantitative<br />

PCR (especially <strong>of</strong> point mutations) are considerable, but histochemical assays <strong>of</strong> enzymatic<br />

activity (which <strong>of</strong> course detect point mutations just as well as deletions) had by the early<br />

1990s clearly excluded the possibility that the total mtDNA mutation load reached such<br />

levels in normal aging. This could be (and indeed has been: see Chapter 9) seen as a challenge<br />

to the relevance <strong>of</strong> mtDNA decline in aging, since the survival—albeit in poor health—<strong>of</strong><br />

people with lots <strong>of</strong> mtDNA damage surely meant that the low levels seen in normal aging<br />

were essentially harmless. But the alternative interpretation is that these inherited mutations<br />

are not knockouts, but in fact only reduce the OXPHOS activity <strong>of</strong> cells by a rather small<br />

degree. Most spontaneous mutations, by contrast, would be severe,* and would therefore<br />

have a phenotypic effect when present at much lower levels.<br />

This interpretation makes sense <strong>of</strong> the curious observation that all known inherited,<br />

disease-causing mtDNA mutations in protein-coding genes are missense mutations, which<br />

change one amino acid, as opposed to deletions or nonsense mutations, which remove or<br />

truncate the encoded protein and are therefore generally more severe. (This is in contrast to<br />

sporadic, non-inherited mtDNA-linked diseases, which exhibit similar symptoms and are<br />

<strong>of</strong>ten associated with mtDNA deletions.) 82 <strong>The</strong>se mutations (and those in tRNA genes) are<br />

known to inhibit OXPHOS severely in vitro, 81 but again one must be cautious, because this<br />

* If most spontaneous mutations are deletions then this is certainly true, but if most are point mutations then<br />

it needs some defending, since typical amino acid substitutions in typical genes do not completely abolish<br />

their function. But it must be taken into account that all the mt-coded proteins are subunits <strong>of</strong> complex<br />

multimeric enzymes; proteins <strong>of</strong> this sort are more sensitive to amino acid changes than average.<br />

79

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!